keyword
https://read.qxmd.com/read/38634823/-correction-to-understanding-and-rescuing-the-splicing-defect-caused-by-the-frequent-abca4-variant-c-4253%C3%A2-%C3%A2-43g-a-underlying-stargardt-disease-by-nuria-su%C3%A3-rez-herrera-et-al-nucleic-acid-ther-2024-34-2-73-82-doi-10-1089-nat-2023-0076
#1
https://read.qxmd.com/read/38615588/generation-of-two-induced-pluripotent-stem-cell-lines-lvpeii007-b-lvpeii008-b-from-patients-harboring-homozygous-mutation-in-abca4-c-6088c-t-using-non-integrative-sendai-virus-based-approach
#2
JOURNAL ARTICLE
Divya Pidishetty, Savitri Maddileti, Sudipta Mahato, Trupti Agrawal, Vinay Kumar Pulimamidi, Milind Naik, Chitra Kannabiran, Subhadra Jalali, Indumathi Mariappan
Mutations in ABCA4 gene leads to the most common form of an inherited retinal disease namely, the Stargardt disease, type 1. Here, we report the generation of two different patient-specific induced pluripotent stem cell lines (LVPEIi007-B and LVPEIi008-B), carrying an identical homozygous mutation, (c.6088C>T) within the exon 44 of ABCA4 gene. These lines were generated by the reprogramming of patient-specific dermal fibroblasts, using the integration-free, Sendai viral vectors. Both lines were stably expanded and expressed the stemness and pluripotency markers, differentiated into cell types of all three germ layers, and maintained a normal karyotype...
April 9, 2024: Stem Cell Research
https://read.qxmd.com/read/38607040/preclinical-development-of-antisense-oligonucleotides-to-rescue-aberrant-splicing-caused-by-an-ultrarare-abca4-variant-in-a-child-with-early-onset-stargardt-disease
#3
JOURNAL ARTICLE
Nuria Suárez-Herrera, Catherina H Z Li, Nico Leijsten, Dyah W Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P M Cremers, Carel B Hoyng, Alejandro Garanto, Rob W J Collin
Precision medicine is rapidly gaining recognition in the field of (ultra)rare conditions, where only a few individuals in the world are affected. Clinical trial design for a small number of patients is extremely challenging, and for this reason, the development of N-of-1 strategies is explored to accelerate customized therapy design for rare cases. A strong candidate for this approach is Stargardt disease (STGD1), an autosomal recessive macular degeneration characterized by high genetic and phenotypic heterogeneity...
March 29, 2024: Cells
https://read.qxmd.com/read/38602673/representation-of-women-among-individuals-with-mild-variants-in-abca4-associated-retinopathy-a-meta-analysis
#4
JOURNAL ARTICLE
Stéphanie S Cornelis, Joanna IntHout, Esmee H Runhart, Olivier Grunewald, Siying Lin, Zelia Corradi, Mubeen Khan, Rebekkah J Hitti-Malin, Laura Whelan, G Jane Farrar, Dror Sharon, L Ingeborgh van den Born, Gavin Arno, Mark Simcoe, Michel Michaelides, Andrew R Webster, Susanne Roosing, Omar A Mahroo, Claire-Marie Dhaenens, Frans P M Cremers
IMPORTANCE: Previous studies indicated that female sex might be a modifier in Stargardt disease, which is an ABCA4-associated retinopathy. OBJECTIVE: To investigate whether women are overrepresented among individuals with ABCA4-associated retinopathy who are carrying at least 1 mild allele or carrying nonmild alleles. DATA SOURCES: Literature data, data from 2 European centers, and a new study. Data from a Radboudumc database and from the Rotterdam Eye Hospital were used for exploratory hypothesis testing...
April 11, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38568448/nationwide-epidemiologic-survey-on-incidence-of-macular-dystrophy-in-japan
#5
JOURNAL ARTICLE
Shinji Ueno, Takaaki Hayashi, Kazushige Tsunoda, Takuya Aoki, Mineo Kondo
PURPOSE: The aim of this study was to estimate the number of patients in Japan who had visited an ophthalmologist for macular dystrophy of various types, including Best vitelliform macular dystrophy (BVMD), Stargardt disease, occult macular dystrophy (OMD), cone (-rod) dystrophy, X-linked retinoschisis (XLRS), and central areolar choroid dystrophy (CACD). STUDY DESIGN: Nationwide epidemiologic survey METHODS: Questionnaires were distributed to 965 major facilities, including all the university hospitals in Japan...
April 3, 2024: Japanese Journal of Ophthalmology
https://read.qxmd.com/read/38491770/harmonizing-regulatory-market-approval-of-products-with-high-safety-requirements-evidence-from-the-european-pharmaceutical-market
#6
JOURNAL ARTICLE
Fabian Grünwald, Tom Stargardt
We causally analyzed whether being a member of the European Union (EU) and having access to a centralized marketing authorization procedure (centralized procedure [CP]) affects availability and time to launch of new pharmaceuticals. We employed multiple difference-in-differences models, exploiting the eastern enlargement of the EU as well as changes in the indications that fall within the compulsory or voluntary scope of the CP. Results showed that countries experienced a mean decrease in launch delay of 10...
March 15, 2024: Health Economics
https://read.qxmd.com/read/38484106/longitudinal-adaptive-optics-scanning-laser-ophthalmoscopy-reveals-regional-variation-in-cone-and-rod-photoreceptor-loss-in-stargardt-disease
#7
JOURNAL ARTICLE
Hongxin Song, Hui Hang, Kaiwen Li, Ethan A Rossi, Jie Zhang
PURPOSE: To investigate the temporal sequence of changes in the photoreceptor cell mosaic in patients with Stargardt disease type 1 (STGD1), using adaptive optics scanning laser ophthalmoscopy (AOSLO). METHODS: Two brothers with genetically confirmed STGD1 underwent comprehensive eye exams, spectral-domain optical coherence tomography (SD-OCT), fundus auto fluorescence (FAF) and AOSLO imaging 3 times over the course of 28 months. Confocal images of the cones and rods were obtained from the central fovea to 10 degrees inferiorly...
March 13, 2024: Retina
https://read.qxmd.com/read/38466963/understanding-and-rescuing-the-splicing-defect-caused-by-the-frequent-abca4-variant-c-4253-43g-a-underlying-stargardt-disease
#8
JOURNAL ARTICLE
Nuria Suárez-Herrera, Alejandro Garanto, Rob W J Collin
Pathogenic variants in ABCA4 are the underlying molecular cause of Stargardt disease (STGD1), an autosomal recessive macular dystrophy characterized by a progressive loss of central vision. Among intronic ABCA4 variants, c.4253+43G>A is frequently detected in STGD1 cases and is classified as a hypomorphic allele, generally associated with late-onset cases. This variant was previously reported to alter splicing regulatory sequences, but the splicing outcome is not fully understood yet. In this study, we attempted to better understand its effect on splicing and to rescue the aberrant splicing via antisense oligonucleotides (AONs)...
March 12, 2024: Nucleic Acid Therapeutics
https://read.qxmd.com/read/38465142/expanding-the-genotype-phenotype-correlations-and-mutational-spectrum-in-inherited-retinal-diseases-novel-and-recurrent-mutations
#9
JOURNAL ARTICLE
Ibrahim Sahin, Haktan B Erdem, Taha Bahsi, Hanife Saat
Background Inherited retinal diseases (IRD) represent a prominent etiology of visual impairment on a global scale. The lack of a clear definition of the etiology and genotypic spectrum of IRD is attributed to the significant genetic variability seen. Additionally, there is a scarcity of available data about the correlations between genotypes and phenotypes in this context. This study aimed to clarify the range of mutations and the associations between genotypes and phenotypes in IRD. Methods This cohort consists of 223 patients who have been diagnosed with a range of retinal illnesses, such as retinitis pigmentosa (RP), Stargardt (STGD)/STGD-like disease, Usher syndrome, and Leber congenital amaurosis (LCA)...
February 2024: Curēus
https://read.qxmd.com/read/38447745/from-health-to-wellbeing-towards-a-monetary-valuation-of-a-wellbeing-adjusted-life-year
#10
JOURNAL ARTICLE
Carolin Brinkmann, Tom Stargardt, Werner B F Brouwer
OBJECTIVES: Economic evaluations using broader measures to capture benefits beyond improved health can inform policy-making, but only if the monetary value of gains measured using these instruments is understood. This study explored contingent valuation as a method to estimate the monetary value of a wellbeing-adjusted life year (WALY) as measured by ICECAP-A. METHODS: In a large online survey of representative samples from seven European countries, participants valued a change in the ICECAP-A from their current health state to a randomly assigned hypothetical state...
March 4, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38443629/intravitreal-delivery-of-pegylated-eco-plasmid-dna-nanoparticles-for-gene-therapy-of-stargardt-disease
#11
JOURNAL ARTICLE
Da Sun, Wenyu Sun, Song-Qi Gao, Jonathan Lehrer, Hong Wang, Ryan Hall, Zheng-Rong Lu
OBJECTIVE: Current gene therapy of inherited retinal diseases is achieved mainly by subretinal injection, which is invasive with severe adverse effects. Intravitreal injection is a minimally invasive alternative for gene therapy of inherited retinal diseases. This work explores the efficacy of intravitreal delivery of PEGylated ECO (a multifunctional pH-sensitive amphiphilic amino lipid) plasmid DNA (pGRK1-ABCA4-S/MAR) nanoparticles (PEG-ELNP) for gene therapy of Stargardt disease. METHODS: Pigmented Abca4-/- knockout mice received 1 µL of PEG-ELNP solution (200 ng/uL, pDNA concentration) by intravitreal injections at an interval of 1...
March 5, 2024: Pharmaceutical Research
https://read.qxmd.com/read/38431596/cell-therapy-for-retinal-degenerative-disorders-a-systematic-review-and-three-level-meta-analysis
#12
REVIEW
Alireza Soltani Khaboushan, Negar Ebadpour, Mohammad Mehdi Johari Moghadam, Zahra Rezaee, Abdol-Mohammad Kajbafzadeh, Masoumeh Majidi Zolbin
BACKGROUND: Retinal degenerative disorders (RDDs) cause vision loss by damaging retinal neurons and photoreceptors, affecting individuals of all ages. Cell-based therapy has emerged as an effective approach for the treatment of RDDs with promising results. This meta-analysis aims to comprehensively evaluate the efficacy of cell therapy in treating age-related macular degeneration (AMD), retinitis pigmentosa (RP), and Stargardt macular degeneration (SMD) as the most prevalent RDDs. METHODS: PubMed, Scopus, Web of Science, and Embase were searched using keywords related to various retinal diseases and cell therapy treatments until November 25th, 2023...
March 2, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38429885/inflammatory-bowel-disease-ibd-patients-with-impaired-quality-of-life-on-biologic-therapy-benefit-from-the-support-of-an-ibd-nurse-specialist-results-of-a-randomised-controlled-trial-in-germany-ibd-bio-assist-study
#13
JOURNAL ARTICLE
Bernd Bokemeyer, Sandra Plachta-Danielzik, Isa Maria Steiner, Daniela Pohlschneider, Eugen Urzica, Petra Hartmann, Jennifer Zemke, Ulrich Tappe, Stefan Schreiber, Nadine Steinkat, Jana Langbrandtner, Angelika Hüppe, Tom Stargardt
BACKGROUND: IBDBIO-ASSIST was a randomised controlled trial assessing the efficacy of care provided by IBD nurse specialists in Germany in improving health-related quality of life (QoL) in IBD patients on biologic therapy. AIM: To evaluate patient-related outcomes and economic consequences associated with integrating IBD nurses into usual care. METHODS: We randomly assigned 1086 patients with IBD on biologic therapy to a control group (CG) receiving usual care or an intervention group (IG) receiving additional care from an IBD nurse specialist...
March 1, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38427967/the-peripapillary-retina-a-common-juncture-in-stargardt-disease-and-idiopathic-intracranial-hypertension
#14
JOURNAL ARTICLE
Jin Kyun Oh, Meital Ben Dov, Stephen H Tsang, Jeffrey G Odel
PURPOSE: To present the multimodal imaging and functional exam findings in a case of combined Stargardt disease and idiopathic intracranial hypertension. METHODS: The patient was evaluated with multimodal imaging including color fundus photography, short wavelength autofluorescence, spectral domain optical coherence tomography as well as functional testing such as Humphrey visual fields and full-field electroretinogram. RESULTS: A 35-year-old woman was referred for evaluation of bilateral transient visual obscurations over the course of 2 months...
March 1, 2024: Retinal Cases & Brief Reports
https://read.qxmd.com/read/38408857/automated-identification-of-fleck-lesions-in-stargardt-disease-using-deep-learning-enhances-lesion-detection-sensitivity-and-enables-morphometric-analysis-of-flecks
#15
JOURNAL ARTICLE
Jasdeep Sabharwal, Tin Yan Alvin Liu, Bani Antonio-Aguirre, Mya Abousy, Tapan Patel, Cindy X Cai, Craig K Jones, Mandeep S Singh
PURPOSE: To classify fleck lesions and assess artificial intelligence (AI) in identifying flecks in Stargardt disease (STGD). METHODS: A retrospective study of 170 eyes from 85 consecutive patients with confirmed STGD. Fundus autofluorescence images were extracted, and flecks were manually outlined. A deep learning model was trained, and a hold-out testing subset was used to compare with manually identified flecks and for graders to assess. Flecks were clustered using K-means clustering...
February 26, 2024: British Journal of Ophthalmology
https://read.qxmd.com/read/38405807/recurrent-and-concurrent-prediction-of-longitudinal-progression-of-stargardt-atrophy-and-geographic-atrophy
#16
Zubin Mishra, Ziyuan Wang, Emily Xu, Sophia Xu, Iyad Majid, SriniVas R Sadda, Zhihong Jewel Hu
Stargardt disease and age-related macular degeneration are the leading causes of blindness in the juvenile and geriatric populations, respectively. The formation of atrophic regions of the macula is a hallmark of the end-stages of both diseases. The progression of these diseases is tracked using various imaging modalities, two of the most common being fundus autofluorescence (FAF) imaging and spectral-domain optical coherence tomography (SD-OCT). This study seeks to investigate the use of longitudinal FAF and SD-OCT imaging (month 0, month 6, month 12, and month 18) data for the predictive modelling of future atrophy in Stargardt and geographic atrophy...
February 13, 2024: medRxiv
https://read.qxmd.com/read/38369462/-abca4-variant-screening-in-a-turkish-cohort-with-stargardt-disease
#17
JOURNAL ARTICLE
Neslihan Sinim Kahraman, Büşra Özgüç Çalışkan, Nefise Kandemir, Ayşe Öner, Munis Dündar, Yusuf Özkul
PURPOSE: This study aims to evaluate the ABCA4 variants in patients diagnosed with Stargardt disease. METHODS: This is a retrospective study designed to investigate variants in the ABCA4 in Stargardt disease and the clinical findings of the cases. Sex, age, age of onset of symptoms, best-corrected visual acuity, color fundus photography, optical coherence tomography, and visual field test of the patients were recorded. Genetic analyses were screened, and patients with at least two variants in the ABCA4 were included in this study...
February 18, 2024: Ophthalmic Genetics
https://read.qxmd.com/read/38362909/cost-effectiveness-analysis-of-empagliflozin-for-treatment-of-patients-with-heart-failure-with-reduced-ejection-fraction-in-the-united-states
#18
JOURNAL ARTICLE
Odette S Reifsnider, Ali Tafazzoli, Stephan Linden, Jack Ishak, Pal Rakonczai, Matthew Stargardter, Effie Kuti
BACKGROUND: In the EMPEROR-Reduced trial (Empagliflozin Outcome Trial in Patients with Chronic Heart Failure and a Reduced Ejection Fraction), empagliflozin plus standard of care reduced the composite of cardiovascular death or hospitalization for heart failure versus standard of care in adults with heart failure with reduced ejection fraction. This analysis investigated the cost-effectiveness of the 2 regimens from the perspective of US payors. METHODS AND RESULTS: A Markov cohort model was developed based on Kansas City Cardiomyopathy Questionnaire Clinical Summary Score quartiles and death...
February 16, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38311892/inner-retinal-thickness-in-stargardt-disease
#19
JOURNAL ARTICLE
Maurizio Battaglia Parodi, Alessandro Arrigo, Lorenzo Bianco, Alessio Antropoli, Andrea Saladino, Lorenzo Pili, Adelaide Pina, Marco Battista, Francesco Bandello
PURPOSE: To analyze the alterations at the level of the inner retina in patients affected by Stargardt disease (STGD1). METHODS: Cross-sectional investigation involving STGD1 patients with genetically confirmed diagnosis, who underwent optical coherence tomography (OCT), optical coherence tomography angiography (OCTA), and microperimetry. RESULTS: Overall, 31 patients (62 eyes) with genetically confirmed STGD1 were included in the study. Mean inner retinal thickness, vessel density of plexa, and retinal sensitivity resulted significantly reduced in STGD patients, compared with healthy controls ( p  < 0...
February 4, 2024: European Journal of Ophthalmology
https://read.qxmd.com/read/38278208/phenotyping-and-genotyping-inherited-retinal-diseases-molecular-genetics-clinical-and-imaging-features-and-therapeutics-of-macular-dystrophies-cone-and-cone-rod-dystrophies-rod-cone-dystrophies-leber-congenital-amaurosis-and-cone-dysfunction-syndromes
#20
REVIEW
Michalis Georgiou, Anthony G Robson, Kaoru Fujinami, Thales A C de Guimarães, Yu Fujinami-Yokokawa, Malena Daich Varela, Nikolas Pontikos, Angelos Kalitzeos, Omar A Mahroo, Andrew R Webster, Michel Michaelides
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age population and children. The scope of this review is to familiarise clinicians and scientists with the current landscape of molecular genetics, clinical phenotype, retinal imaging and therapeutic prospects/completed trials in IRD. Herein we present in a comprehensive and concise manner: (i) macular dystrophies (Stargardt disease (ABCA4), X-linked retinoschisis (RS1), Best disease (BEST1), PRPH2-associated pattern dystrophy, Sorsby fundus dystrophy (TIMP3), and autosomal dominant drusen (EFEMP1)), (ii) cone and cone-rod dystrophies (GUCA1A, PRPH2, ABCA4, KCNV2 and RPGR), (iii) predominant rod or rod-cone dystrophies (retinitis pigmentosa, enhanced S-Cone syndrome (NR2E3), Bietti crystalline corneoretinal dystrophy (CYP4V2)), (iv) Leber congenital amaurosis/early-onset severe retinal dystrophy (GUCY2D, CEP290, CRB1, RDH12, RPE65, TULP1, AIPL1 and NMNAT1), (v) cone dysfunction syndromes (achromatopsia (CNGA3, CNGB3, PDE6C, PDE6H, GNAT2, ATF6), X-linked cone dysfunction with myopia and dichromacy (Bornholm Eye disease; OPN1LW/OPN1MW array), oligocone trichromacy, and blue-cone monochromatism (OPN1LW/OPN1MW array)...
January 24, 2024: Progress in Retinal and Eye Research
keyword
keyword
112494
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.